| Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives | |
| He Niya; Li Qing; Wu Chunyan; Ren Zhong; Gao Ya; Pan Lihong; Wang Meimei; Wen Hongyan; Jiang Zhisheng; Tang Zhihan | |
| 刊名 | Acta Pharmacologica Sinica
 |
| 2017 | |
| 卷号 | 38期号:3页码:301-311 |
| 关键词 | PCSK9 LDL receptor monoclonal antibodies anti-sense oligonucleotide mimetic peptides adnectin CRISPR/Cas9 platform berberine oleanollc acid neuronal apoptosis coronary artery disease cholesterol metabolism |
| ISSN号 | 1671-4083 |
| DOI | 10.1038/aps.2016.134 |
| URL标识 | 查看原文 |
| WOS记录号 | WOS:000395792800001;PMID:28112180 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/5677567 |
| 专题 | 南华大学 |
| 作者单位 | 1.[Gao Ya 2.Jiang Zhisheng 3.Ren Zhong 4.Li Qing 5.Tang Zhihan 6.Tang, ZH 7.Liu Lushan 8.He Niya 9.Wang Meimei 10.Wu Chunyan |
| 推荐引用方式 GB/T 7714 | He Niya,Li Qing,Wu Chunyan,et al. Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives[J]. Acta Pharmacologica Sinica,2017,38(3):301-311. |
| APA | He Niya.,Li Qing.,Wu Chunyan.,Ren Zhong.,Gao Ya.,...&Liu Lushan.(2017).Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives.Acta Pharmacologica Sinica,38(3),301-311. |
| MLA | He Niya,et al."Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives".Acta Pharmacologica Sinica 38.3(2017):301-311. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论